- Home
- KRYS vs VRNS Comparison
KRYS vs VRNS Comparison
Compare KRYS & VRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRYS
- VRNS
- Stock Information
- Founded
- KRYS 2015
- VRNS 2004
- Country
- KRYS United States
- VRNS United States
- Employees
- KRYS N/A
- VRNS N/A
- Industry
- KRYS Biotechnology: Biological Products (No Diagnostic Substances)
- VRNS Computer Software: Prepackaged Software
- Sector
- KRYS Health Care
- VRNS Technology
- Exchange
- KRYS Nasdaq
- VRNS Nasdaq
- Market Cap
- KRYS 4.6B
- VRNS 5.0B
- IPO Year
- KRYS 2017
- VRNS 2014
- Fundamental
- Price
- KRYS $187.96
- VRNS $42.97
- Analyst Decision
- KRYS Strong Buy
- VRNS Buy
- Analyst Count
- KRYS 7
- VRNS 17
- Target Price
- KRYS $210.00
- VRNS $59.38
- AVG Volume (30 Days)
- KRYS 245.3K
- VRNS 2.2M
- Earning Date
- KRYS 02-19-2025
- VRNS 02-04-2025
- Dividend Yield
- KRYS N/A
- VRNS N/A
- EPS Growth
- KRYS 669.23
- VRNS N/A
- EPS
- KRYS 3.00
- VRNS N/A
- Revenue
- KRYS $290,515,000.00
- VRNS $550,950,000.00
- Revenue This Year
- KRYS $483.09
- VRNS $14.95
- Revenue Next Year
- KRYS $57.70
- VRNS $16.27
- P/E Ratio
- KRYS $62.62
- VRNS N/A
- Revenue Growth
- KRYS 473.02
- VRNS 10.38
- 52 Week Low
- KRYS $109.57
- VRNS $39.62
- 52 Week High
- KRYS $219.34
- VRNS $60.58
- Technical
- Relative Strength Index (RSI)
- KRYS 73.39
- VRNS 44.39
- Support Level
- KRYS $148.00
- VRNS $42.54
- Resistance Level
- KRYS $190.00
- VRNS $44.55
- Average True Range (ATR)
- KRYS 7.31
- VRNS 1.65
- MACD
- KRYS 3.66
- VRNS 0.08
- Stochastic Oscillator
- KRYS 93.87
- VRNS 45.39
About KRYS Krystal Biotech Inc.
Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.
About VRNS Varonis Systems Inc.
Varonis Systems is a cybersecurity vendor focused on data privacy and security. The firm is currently undergoing a cloud transition as it weans its on-premises customers over to its cloud products that are delivered as software-as-a-service. The New York-based firm was founded in 2005 and went public in 2014.